Amphotericin B derivatives with improved therapeutic index
Attorney Docket No. UIX-014.25 Provided are certain derivatives of amphotericin B (AmB) characterized by reduced toxicity and retained anti-fungal activity. Certain of the derivatives are C16 urea derivatives ofAmB. Certain of the derivatives are C3, C5, C8, C9, C1I, C13, or C15 5 deoxy derivatives...
Saved in:
Main Authors | , , , , , , , , |
---|---|
Format | Patent |
Language | English |
Published |
16.01.2020
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Attorney Docket No. UIX-014.25 Provided are certain derivatives of amphotericin B (AmB) characterized by reduced toxicity and retained anti-fungal activity. Certain of the derivatives are C16 urea derivatives ofAmB. Certain of the derivatives are C3, C5, C8, C9, C1I, C13, or C15 5 deoxy derivatives of AmB. Certain of the derivatives include C3'or C4' modifications of the mycosamine appendage of AmB. Also provided are methods of making AmB derivatives of the invention, pharmaceutical compositions comprising AmB derivatives of the invention, and methods of use of AmB derivatives of the invention. - 65- Figure 1 HO OH OH OHOHOH HO /'MeO OH OH OH OH O,,,16R OR' 0 Me amphotericin B (AmB) COOH OH 0 Me amphotericin B methyl ester (AmBME) COOMe OH amphoternolide (AmdeB) COOH H 0 Me C2'deoxy amphotericin B (C2'deOAmB) COOH OH |
---|---|
Bibliography: | Application Number: AU20190279928 |